About Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial to verify the efficacy and safety of high-dose methylcobalamin (mecobalamin) in patients with amyotrophic lateral sclerosis (ALS)
When we try to think about drug development in the future, we cant assume that the mechanisms that we see in a typical brain necessarily apply to someone with autism, McAlonan says
Intrinsic factor is essential for B12 absorption in the terminal ileum
GHK-Cu 100mg is not the same type of peptide as BPC-157, but it is an adjacent research compound because it is studied in extracellular matrix, collagen, copper peptide and wound biology models
Wounds exposed to GHK were reported to contain lower concentrations of the pro-inflammatory markers, including tumor necrosis factor-alpha (TNF-alpha), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9)
In December of 2024, I received cheek filler, Botox, and lip filler for the first time ever